Stifel Reiterates Buy Rating on Amicus Therapeutics (FOLD)

July 8, 2024 12:25 PM EDT Send to a Friend
Stifel analyst Dae Gon Ha reiterated a Buy rating and $20.00 price target on Amicus Therapeutics (NASDAQ: FOLD).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login